TY - JOUR
T1 - Impact of age on coronary artery plaque progression and clinical outcome
T2 - a PARADIGM substudy
AU - Kim, Minkwan
AU - Lee, Seung Pyo
AU - Kwak, Soongu
AU - Yang, Seokhun
AU - Kim, Yong Jin
AU - Andreini, Daniele
AU - Al-Mallah, Mouaz H.
AU - Budoff, Matthew J.
AU - Cademartiri, Filippo
AU - Chinnaiyan, Kavitha
AU - Choi, Jung Hyun
AU - Conte, Edoardo
AU - Marques, Hugo
AU - Gonçalves, Pedro de Araújo
AU - Gottlieb, Ilan
AU - Hadamitzky, Martin
AU - Leipsic, Jonathon A.
AU - Maffei, Erica
AU - Pontone, Gianluca
AU - Raff, Gilbert L.
AU - Shin, Sanghoon
AU - Lee, Byoung Kwon
AU - Chun, Eun Ju
AU - Sung, Ji Min
AU - Lee, Sang Eun
AU - Berman, Daniel S.
AU - Lin, Fay Y.
AU - Virmani, Renu
AU - Samady, Habib
AU - Stone, Peter H.
AU - Narula, Jagat
AU - Bax, Jeroen J.
AU - Shaw, Leslee J.
AU - Min, James K.
AU - Chang, Hyuk Jae
N1 - Funding Information:
This work was supported by grants through the National Research Foundation (NRF) of Korea funded by the Ministry of Science and ICT (MSIT) (Grant No. 2012027176 & No. 2019R1A2C2084099). The study was also funded in part by a generous gift from the Dalio Institute of Cardiovascular Imaging and the Michael Wolk Foundation. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.Dr. Min receives funding from the Dalio Foundation, National Institutes of Health, and GE Healthcare and serves on the scientific advisory board of Arineta and GE Healthcare, and has an equity interest in Clearly. Dr. Samady serves on the scientific advisory board of Philips, has equity interest in Covanos Inc., and has a research grant from Medtronic. The remaining authors have no relevant disclosures.
Funding Information:
This work was supported by grants through the National Research Foundation (NRF) of Korea funded by the Ministry of Science and ICT (MSIT) (Grant No. 2012027176 & No. 2019R1A2C2084099 ). The study was also funded in part by a generous gift from the Dalio Institute of Cardiovascular Imaging and the Michael Wolk Foundation. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
Publisher Copyright:
© 2020 Society of Cardiovascular Computed Tomography
PY - 2021/5/1
Y1 - 2021/5/1
N2 - Background: The association of age with coronary plaque dynamics is not well characterized by coronary computed tomography angiography (CCTA). Methods: From a multinational registry of patients who underwent serial CCTA, 1153 subjects (61 ± 5 years old, 61.1% male) were analyzed. Annualized volume changes of total, fibrous, fibrofatty, necrotic core, and dense calcification plaque components of the whole heart were compared by age quartile groups. Clinical events, a composite of all-cause death, acute coronary syndrome, and any revascularization after 30 days of the initial CCTA, were also analyzed. Random forest analysis was used to define the relative importance of age on plaque progression. Results: With a 3.3-years’ median interval between the two CCTA, the median annual volume changes of total plaque in each age quartile group was 7.8, 10.5, 10.8, and 12.1 mm3/year and for dense calcification, 2.5, 4.6, 5.4, and 7.1 mm3/year, both of which demonstrated a tendency to increase by age (p-for-trend = 0.001 and < 0.001, respectively). However, this tendency was not observed in any other plaque components. The annual volume changes of total plaque and dense calcification were also significantly different in the propensity score-matched lowest age quartile group versus the other age groups as was the composite clinical event (log-rank p = 0.003). In random forest analysis, age had comparable importance in the total plaque volume progression as other traditional factors. Conclusions: The rate of whole-heart plaque progression and dense calcification increases depending on age. Age is a significant factor in plaque growth, the importance of which is comparable to other traditional risk factors. Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifiers: NCT02803411.
AB - Background: The association of age with coronary plaque dynamics is not well characterized by coronary computed tomography angiography (CCTA). Methods: From a multinational registry of patients who underwent serial CCTA, 1153 subjects (61 ± 5 years old, 61.1% male) were analyzed. Annualized volume changes of total, fibrous, fibrofatty, necrotic core, and dense calcification plaque components of the whole heart were compared by age quartile groups. Clinical events, a composite of all-cause death, acute coronary syndrome, and any revascularization after 30 days of the initial CCTA, were also analyzed. Random forest analysis was used to define the relative importance of age on plaque progression. Results: With a 3.3-years’ median interval between the two CCTA, the median annual volume changes of total plaque in each age quartile group was 7.8, 10.5, 10.8, and 12.1 mm3/year and for dense calcification, 2.5, 4.6, 5.4, and 7.1 mm3/year, both of which demonstrated a tendency to increase by age (p-for-trend = 0.001 and < 0.001, respectively). However, this tendency was not observed in any other plaque components. The annual volume changes of total plaque and dense calcification were also significantly different in the propensity score-matched lowest age quartile group versus the other age groups as was the composite clinical event (log-rank p = 0.003). In random forest analysis, age had comparable importance in the total plaque volume progression as other traditional factors. Conclusions: The rate of whole-heart plaque progression and dense calcification increases depending on age. Age is a significant factor in plaque growth, the importance of which is comparable to other traditional risk factors. Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifiers: NCT02803411.
KW - Aging
KW - Atherosclerotic plaque
KW - Computed tomography
KW - Coronary artery disease
KW - Disease progression
UR - http://www.scopus.com/inward/record.url?scp=85092053588&partnerID=8YFLogxK
U2 - 10.1016/j.jcct.2020.09.009
DO - 10.1016/j.jcct.2020.09.009
M3 - Article
C2 - 33032975
AN - SCOPUS:85092053588
SN - 1934-5925
VL - 15
SP - 232
EP - 239
JO - Journal of Cardiovascular Computed Tomography
JF - Journal of Cardiovascular Computed Tomography
IS - 3
ER -